Surgical Science Sweden AB (publ) reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 227.29 million compared to SEK 250.11 million a year ago. Net income was SEK 97.96 million compared to SEK 116.52 million a year ago. Basic earnings per share from continuing operations was SEK 1.92 compared to SEK 2.29 a year ago. Diluted earnings per share from continuing operations was SEK 1.92 compared to SEK 2.29 a year ago.
For the full year, sales was SEK 882.85 million compared to SEK 802.54 million a year ago. Net income was SEK 233.97 million compared to SEK 187.97 million a year ago. Basic earnings per share from continuing operations was SEK 4.59 compared to SEK 3.7 a year ago. Diluted earnings per share from continuing operations was SEK 4.59 compared to SEK 3.69 a year ago.